RE:Datametrex NR ON Cash News this morning regarding the development of Datametrex on AI.
Datametrex talks AI company acquisitions in 2022
2022-01-20 06:24 ET - News Release
Mr. Marshall Gunter reports
DATAMETREX PLANS TO ROLL UP AI INDUSTRY
Datametrex AI Ltd. plans to implement a roll-up strategy focused on artificial intelligence (AI) companies in 2022. As previously announced on January 18, 2022, the Company currently has approximately $20 million in cash and cash equivalent.
As artificial intelligence is becoming a growing influence in business, Datametrex is poised to leverage its AI experience to help reshape the entire industry. Over the last few years, the Company has landed significant AI contracts globally with many entities including International Conglomerates, Government Agencies and Ministries, Financial Services, and International Airports.
"As a CEO with a strong computer science background, I have seen AI produce huge changes to how we conduct our lives, from basic machine learning to business intelligence and automation to analytics; the possibilities are endless. We feel this opens the door to grow Datametrex exponentially by adding businesses and becoming leaders in these emerging technologies," commented Marshall Gunter, CEO of Datametrex.
According to PwC's Global Artificial Intelligence Study: Exploiting the AI Revolution as quoted by Forbes, "AI contributed a whopping $2 trillion to global GDP last year. By 2030, it could be as much as $15.7 trillion, making it the biggest commercial opportunity in today's fast-changing economy." (Sourced online January 13, 2022)
For more information on this project or to learn how Datametrex can assist your organization in social media discovery or cyber security please go to: www.nexalogy.com.
About Datametrex
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.
We seek Safe Harbor.
© 2022 Canjex Publishing Ltd. All rights reserved.
Smokey1958 wrote:
Agree wholeheartedly with the sentiments expressed thus far and would only add that cash on hand is even more relevant to ScreenPro.
Datametrex has a clear vision and developments/contracts that will see it expand and generate significant revenues post covid (end of 2022???). SCRN, on the other hand, needs to, and I believe will, diversify to move beyond covid, even in the world of testing. Imho it will be important at some time in the future for them to chart their own course, independent of DM ....which I again believe they will do.
In the meantime covid testing revenues (profits) that must be increasing significantly, based on the Datametrex NR, will be the catalyst for this diversification. As Morningstar's Fair Value sp still sits at $.07 today and the shorterm to longterm moving averages are steady at BUY things are looking up if the sp could sustainably bust free of $.03.
GLTE!!!